Comment on the article entitled Intravitreal bevacizumab as single drug therapy for retinopathy of prematurity in 12 patients

dc.contributor.authorSahin, Alparslan
dc.contributor.authorMurat, Mehmet
dc.date.accessioned2024-04-24T17:27:50Z
dc.date.available2024-04-24T17:27:50Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.5546/aap.2014.160
dc.identifier.endpageE241en_US
dc.identifier.issn0325-0075
dc.identifier.issn1668-3501
dc.identifier.issue5en_US
dc.identifier.scopus2-s2.0-84908238882
dc.identifier.scopusqualityQ3
dc.identifier.startpageE240en_US
dc.identifier.urihttps://doi.org/10.5546/aap.2014.160
dc.identifier.urihttps://hdl.handle.net/11468/20220
dc.identifier.volume112en_US
dc.identifier.wosWOS:000346922900011
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherSoc Argentina Pediatriaen_US
dc.relation.ispartofArchivos Argentinos De Pediatria
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keyword]en_US
dc.titleComment on the article entitled Intravitreal bevacizumab as single drug therapy for retinopathy of prematurity in 12 patientsen_US
dc.titleComment on the article entitled Intravitreal bevacizumab as single drug therapy for retinopathy of prematurity in 12 patients
dc.typeLetteren_US

Dosyalar